Profiles
News
EMA Recommends Granting a Marketing Authorisation for Generic Trabectedin
Trabectedin Accord is a generic of Yondelis, which has been authorised in the EU since 2007
Supporters
Find out more information about the supporters of ESMO AI & Digital Oncology Congress 2025
Certificate of Attendance
The Evaluation Questionnaire along with the certificate of attendance will be available from Saturday, 17 May at 10:00 CEST
News
ESMO Urges Action on Cancer at 2025 UN High-Level Forum on Sustainable Development
As the UN prepares for the 2025 High-Level Political Forum on Sustainable Development (HLPF) from 14–23 July, ESMO urges stronger global action on cancer under Sustainable Development Goal 3 (SDG 3) ‘Ensuring healthy lives and promoting well-being for all’ to ensure no patient is left behind
Educational material
ESMO E-Learning: Multidisciplinary Treatment of Medulloblastoma
E-Learning module by Dr Franceschi. Watch the presentation and take the CME test.
E-Learning
ESMO E-Learning: PARP Inhibitors in Management of Breast Cancers in Patients with Pathogenic Variants in BRCA1/2
E-Learning module by Dr Geyer. Watch the presentation and take the CME test.